v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Collaboration revenue $ 5,952 $ 5,050
Operating expenses:    
Research and development 21,626 25,534
General and administrative 7,239 7,710
Total operating expenses 28,865 33,244
Loss from operations (22,913) (28,194)
Other income, net:    
Interest income 2,692 2,439
Other income, net 1,387 739
Total other income, net 4,079 3,178
Net loss $ (18,834) $ (25,016)
Net loss per share attributable to common stockholders—basic (in dollars per share) $ (0.30) $ (0.59)
Net loss per share attributable to common stockholders—diluted (in dollars per share) $ (0.30) $ (0.59)
Weighted average common shares outstanding—basic (in shares) 62,848,673 42,428,813
Weighted average common shares outstanding—diluted (in shares) 62,848,673 42,428,813
Comprehensive loss:    
Net loss $ (18,834) $ (25,016)
Other comprehensive gain (loss):    
Unrealized gains (losses) on marketable securities (121) 329
Total other comprehensive gain (loss) (121) 329
Total comprehensive loss $ (18,955) $ (24,687)
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Collaboration Revenue [Member] Collaboration Revenue [Member]